ReviewAccounts of chemical research2025
From Mono-
Review in Accounts of chemical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Ligand-Enabled Stereoselective Coupling of Methylene C(spAngewandte Chemie (International ed. in English) · 2026Article
- Article
- Transition Metal-Catalyzed Direct C(spChemical reviews · 2026Review
- Coordination-Induced Spin Modulation: Overcoming Spin Blocking in C-H Methylation with High-Spin Ferrous Complexes.ACS catalysis · 2026Article
- Enantioselective C-H Activation for the Construction of Chiral Tertiary Fluorides via Migrative Carbofluorination.Journal of the American Chemical Society · 2026Article
- Palladium(II)-Catalyzed Nondirected C(spJACS Au · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Functionalization of carbon-hydrogen (C-H) bonds has emerged as a powerful strategy in modern organic synthesis, offering efficient routes to build molecular complexity from simple and abundant substrates. Among various transition-metal catalysts, palladium(II) complexes have proven particularly versatile for C-H activation, owing to the diverse reactivity of carbon-palladium bonds. To advance this approach, the discovery of ligands that can accelerate C-H activation as well as subsequent steps in the catalytic cycle is the pivotal driving force. While ligand development has long been integral to Pd(0) catalysts for activating electrophiles, notably in cross-coupling and asymmetric catalysis, the most common electron-donating ligands often inhibit Pd(II)-catalyzed C-H activation, as an electrophilic palladium center is often preferred. Hence the discovery of a suitable concerted metalation-deprotonation (CMD) motif that can be incorporated into bidentate ligands is critical. This design concept led us to discover a series of highly reactive bifunctional ligands that enhance reactivity and control site-selectivity as well as enantioselectivity.In 2008, our laboratory introduced the first bifunctional mono-
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.